Earnings turnaround for Johnson & Johnson with Q1 2024 financial results

By:
on Apr 16, 2024
Listen
  • On April 15th, Johnson & Johnson reported its latest financial results.
  • The figures represented a welcome turnaround compared to Q1 of 2023.
  • Among other highlights was its 2.3% rise in global sales, compared with last year's losses.

Follow Invezz on Telegram, Twitter, and Google News for instant updates >

Pharmaceutical and consumer staples titan Johnson & Johnson reported its Q1 2024 financial results before US markets opened this morning.

Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.

Johnson & Johnson announced significant turnaround in its net earnings, with $5.3 billion in net earnings for Q1 from continuing operations, versus the $491 million loss of Q1 2023 for the same category.

Sales, operational growth and cash flow

Copy link to section

This was off the back of a 2.3% rise in sales to $21.4 billion globally, with an operational growth of 3.9%.

The figures showed healthy profit margins for the company, despite restructuring expenses of $27 million in the fiscal first quarter of 2024, which primarily included costs related to market and product exits.

EPS and dividend

Copy link to section

Diluted earnings per share (EPS) came in at $2.20 per share for Q1, or a $2.71 adjusted EPS, compared with 2023’s Q1 adjusted EPS of $2.41.

That same morning, the company declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62nd year of consecutive increases.

Dip in sales abroad

Copy link to section

Regional results showed that worldwide sales increased marginally, by 2.3%, while international sales decreased by 3.4%. In the US, however, sales rose by a more robust 7.8%.

The Johnson & Johnson stock price

Copy link to section

The shares of the company were trading well before markets opened on Tuesday, up $147.59 (approximately 0.04%) before Johnson & Johsnon posted their earnings.

Ad

Want easy-to-follow crypto, forex & stock trading signals? Make trading simple by copying our team of pro-traders. Consistent results. Sign-up today at Invezz Signals™.

0/10
Learn more
Johnson & Johnson Earnings Reports Stock Market